Two Sigma Investments’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,100
Closed -$1.38M 3420
2021
Q4
$1.38M Sell
2,100
-1,900
-48% -$1.19M ﹤0.01% 2269
2021
Q3
$2.49M Buy
4,000
+3,000
+300% +$2.02M 0.01% 1782
2021
Q2
$632K Buy
1,000
+100
+11% +$55.2K ﹤0.01% 2896
2021
Q1
$440K Sell
900
-400
-31% -$200K ﹤0.01% 3049
2020
Q4
$650K Sell
1,300
-3,600
-73% -$1.61M ﹤0.01% 2316
2020
Q3
$1.93M Buy
4,900
+3,900
+390% +$1.44M 0.01% 1316
2020
Q2
$330K Sell
1,000
-2,400
-71% -$695K ﹤0.01% 2309
2020
Q1
$824K Buy
3,400
+600
+21% +$157K 0.01% 1563
2019
Q4
$731K Sell
2,800
-3,900
-58% -$1.03M ﹤0.01% 2486
2019
Q3
$1.82M Buy
+6,700
New +$1.86M 0.01% 1513
2019
Q1
Sell
-7,000
Closed -$1.3M 3232
2018
Q4
$1.3M Buy
+7,000
New +$1.44M 0.01% 1480

Other funds holding IDXX

Two Sigma Investments's IDXX Position: Q1 2026 in Review

Two Sigma Investments reduced its Idexx Laboratories (IDXX) stake by 86% in Q1 2026, selling an estimated $3.85M and leaving 941 shares worth $529K. The position accounts for ﹤0.01% of the portfolio, ranked #3707.

Two Sigma Investments first reported a position in IDXX in Q2 2013 and has held it in 37 quarters since. The position peaked at $103M in Q1 2017. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Two Sigma Investments held 941 shares of Idexx Laboratories worth $529K as of Q1 2026.
  • Two Sigma Investments sold 6,000 Idexx Laboratories shares in Q1 2026, an estimated $3.85M.
  • Idexx Laboratories made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3707 holding.
  • Two Sigma Investments first reported a position in Idexx Laboratories in Q2 2013 and has held it in 37 quarters since.
  • Two Sigma Investments's Idexx Laboratories position peaked at $103M in Q1 2017.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.